Welcome to our dedicated page for Acadia Healthcare Company news (Ticker: $ACHC), a resource for investors and traders seeking the latest updates and insights on Acadia Healthcare Company stock.
Our selection of high-quality news articles is accompanied by an expert summary from Rhea-AI, detailing the impact and sentiment surrounding the news at the time of release, providing a deeper understanding of how each news could potentially affect Acadia Healthcare Company's stock performance. The page also features a concise end-of-day stock performance summary, highlighting the actual market reaction to each news event. The list of tags makes it easy to classify and navigate through different types of news, whether you're interested in earnings reports, stock offerings, stock splits, clinical trials, fda approvals, dividends or buybacks.
Designed with both novice traders and seasoned investors in mind, our page aims to simplify the complex world of stock market news. By combining real-time updates, Rhea-AI's analytical insights, and historical stock performance data, we provide a holistic view of Acadia Healthcare Company's position in the market.
Geisinger and Acadia Healthcare held a groundbreaking ceremony for the construction of a new state-of-the-art, 96-bed behavioral health hospital in Danville, Pennsylvania. The hospital, set to open in spring 2025, will offer inpatient, outpatient, and ECT treatment programs, addressing the need for high-quality behavioral health services in central Pennsylvania and serving adult, pediatric, and adolescent patients.
Acadia Healthcare Company, Inc. (NASDAQ: ACHC) will participate in the BofA Securities Health Care Conference in Las Vegas, Nevada on May 14-16, 2024. The Company's presentation will be webcast on their website at 6:20 p.m. CT / 4:20 p.m. PT on May 14th, 2024, with a replay available for 30 days.
Acadia Healthcare reported solid financial results for the first quarter of 2024 with revenue totaling $768.1 million, a 9.1% increase year-over-year. Same facility revenue increased by 9.2%, net income was $76.4 million, adjusted EBITDA was $173.9 million, and adjusted EBITDA margin was 22.6%. The company affirmed its full year 2024 guidance with revenue expected to range between $3.18 to $3.25 billion and adjusted EBITDA between $730 to $770 million.
